Who owns OnKure Therapeutics, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of OKUR from SEC Form 13F filings across 83 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 83 institutions disclosed 35.4M shares of OnKure Therapeutics, Inc. worth $96.5M — about 70.9% of shares outstanding; the largest disclosed holder is BVF INC/IL. Source: SEC Form 13F filings, parsed by EvidInvest.
83
13F holders
$96.5M
value, 2026 filers
70.9%
of shares outstanding (35.4M sh)
12
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of OKUR's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BVF INC/IL | 4.0M | $11.0M | 0.4% | 8.1% | +25.0% |
| 2 | RA CAPITAL MANAGEMENT, L.P. | 4.0M | $10.9M | 0.1% | 8% | 0.0% |
| 3 | ACORN CAPITAL ADVISORS, LLC | 2.8M | $7.8M | 2.1% | 5.7% | 0.0% |
| 4 | StepStone Group LP | 2.7M | $7.2M | 0.5% | 5.3% | 0.0% |
| 5 | ADAR1 Capital Management, LLC | 2.2M | $6.1M | 0.3% | 4.5% | 0.0% |
| 6 | Vivo Capital, LLC | 1.9M | $5.3M | 0.6% | 3.9% | 0.0% |
| 7 | BlackRock, Inc. | 1.7M | $4.6M | 0.0% | 3.4% | +11.8% |
| 8 | VANGUARD CAPITAL MANAGEMENT LLC | 1.5M | $4.1M | 0.0% | 3% | +3.4% |
| 9 | Prosight Management, LP | 1.3M | $3.6M | 0.7% | 2.7% | +35.4% |
| 10 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.2M | $3.3M | 0.0% | 2.4% | 0.0% |
| 11 | Vestal Point Capital, LP | 1.1M | $3.0M | 0.1% | 2.2% | -40.4% |
| 12 | Sio Capital Management, LLC | 1.1M | $3.0M | 0.6% | 2.2% | +0.4% |
| 13 | BANK OF AMERICA CORP /DE/ | 1.0M | $2.7M | 0.0% | 2% | +842.4% |
| 14 | Logos Global Management LP | 963,855 | $2.6M | 0.1% | 1.9% | 0.0% |
| 15 | GEODE CAPITAL MANAGEMENT, LLC | 720,248 | $2.0M | 0.0% | 1.4% | -0.6% |
| 16 | Trails Edge Capital Partners, LP | 619,557 | $1.7M | 0.2% | 1.2% | -56.9% |
| 17 | CITADEL ADVISORS LLC | 556,493 | $1.5M | 0.0% | 1.1% | -53.1% |
| 18 | NEA Management Company, LLC | 478,548 | $1.3M | 0.1% | 1% | 0.0% |
| 19 | STATE STREET CORP | 473,428 | $1.3M | 0.0% | 0.9% | +2.1% |
| 20 | Ensign Peak Advisors, Inc | 360,762 | $983,076 | 0.0% | 0.7% | -16.4% |
| 21 | MARSHALL WACE, LLP | 355,268 | $969,882 | 0.0% | 0.7% | +122.2% |
| 22 | RENAISSANCE TECHNOLOGIES LLC | 353,150 | $962,334 | 0.0% | 0.7% | -1.6% |
| 23 | Sofinnova Investments, Inc. | 312,553 | $851,707 | 0.0% | 0.6% | -2.8% |
| 24 | Carlyle Group Inc. | 269,895 | $735,464 | 0.0% | 0.5% | 0.0% |
| 25 | Seven Fleet Capital Management LP | 240,963 | $656,624 | 0.1% | 0.5% | 0.0% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.